Literature DB >> 9925881

The role of N-, Q- and R-type Ca2+ channels in feedback inhibition of ACh release from rat basal forebrain neurones.

T G Allen1.   

Abstract

1. The Ca2+ channel subtypes controlling ACh release from basal forebrain neurones and the ionic basis underlying muscarinic receptor-mediated autoinhibition were studied using skeletal myoballs to detect ACh release from individual rat basal forebrain neurones in culture. 2. Somatic Ca2+ currents evoked using a simulated action potential waveform revealed that Ca2+ entry was primarily through N-, Q- and to a lesser extent R-, T- and L-type Ca2+ channels. 3. Muscarine (10 microM) inhibited N- and Q- but not R-, T- or L-type somatic Ca2+ channels. Agonist inhibition was totally blocked by pre-treatment with pertussis toxin (500 ng ml-1). 4. ACh release from discrete sites along basal forebrain neurites (1. 2 mM extracellular Ca2+) could be largely abolished by blocking Ca2+ entry through either N-type or Q-type Ca2+ channels. Inhibition of Ca2+ entry through L- or T-type channels had no effect upon release. Following inhibition of either N- or Q-type Ca2+ channels, release could be restored to near control levels by raising [Ca2+]o. After selectively blocking N-, Q-, L- and T-type channels, low levels of release could still be evoked as a result of Ca2+ entry through R-type Ca2+ channels. 5. Muscarinic receptor activation reversibly inhibited ACh release due to Ca2+ entry through N-, Q- and R-type Ca2+ channels. In contrast, inhibition of inwardly rectifying K+ channels using Ba2+ (3-10 microM) or substance P (0.03-0.1 microM), or block of SK or BK Ca2+-activated K+ channels with apamin (100 nM) or charbydotoxin (100 nM) respectively, had no effect upon either ACh release or its modulation by muscarinic agonists. 6. These results show that ACh release from individual release sites on basal forebrain neurones is controlled by multiple Ca2+ channel subtypes with overlapping Ca2+ microdomains and that autoinhibition of release results from M2 muscarinic receptor-mediated inhibition of these presynaptic Ca2+ channels rather than as a consequence of K+ channel activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925881      PMCID: PMC2269139          DOI: 10.1111/j.1469-7793.1999.093ad.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  48 in total

1.  Action potential waveforms reveal simultaneous changes in ICa and IK produced by 5-HT in rat dorsal raphe neurons.

Authors:  N J Penington; J S Kelly; A P Fox
Journal:  Proc Biol Sci       Date:  1992-05-22       Impact factor: 5.349

2.  P-type calcium channels blocked by the spider toxin omega-Aga-IVA.

Authors:  I M Mintz; V J Venema; K M Swiderek; T D Lee; B P Bean; M E Adams
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

3.  Low access resistance perforated patch recordings using amphotericin B.

Authors:  J Rae; K Cooper; P Gates; M Watsky
Journal:  J Neurosci Methods       Date:  1991-03       Impact factor: 2.390

4.  Multiple Ca2+ currents elicited by action potential waveforms in acutely isolated adult rat dorsal root ganglion neurons.

Authors:  R S Scroggs; A P Fox
Journal:  J Neurosci       Date:  1992-05       Impact factor: 6.167

5.  Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography.

Authors:  M T Vilaró; K H Wiederhold; J M Palacios; G Mengod
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

6.  Action potential waveform voltage-clamp commands reveal striking differences in calcium entry via low and high voltage-activated calcium channels.

Authors:  D P McCobb; K G Beam
Journal:  Neuron       Date:  1991-07       Impact factor: 17.173

7.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

8.  Muscarinic agonists block a late-afterhyperpolarization in medial septum/diagonal band neurons in vitro.

Authors:  J A Sim; W H Griffith
Journal:  Neurosci Lett       Date:  1991-08-05       Impact factor: 3.046

9.  Acetylcholine receptors in dissociated nucleus basalis of Meynert neurons of the rat.

Authors:  N Harata; N Tateishi; N Akaike
Journal:  Neurosci Lett       Date:  1991-09-16       Impact factor: 3.046

10.  A comparison of the effect of calcium channel ligands and GABAB agonists and antagonists on transmitter release and somatic calcium channel currents in cultured neurons.

Authors:  E Huston; R H Scott; A C Dolphin
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

View more
  6 in total

Review 1.  Neurotransmitter modulation of neuronal calcium channels.

Authors:  Keith S Elmslie
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 2.  Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms.

Authors:  David A Brown
Journal:  J Mol Neurosci       Date:  2010-05-06       Impact factor: 3.444

3.  Distribution of voltage gated calcium channel β subunits in the mouse retina.

Authors:  Sherry L Ball; Maureen W McEnery; Anne Marie R Yunker; Hee-Sup Shin; Ronald G Gregg
Journal:  Brain Res       Date:  2011-07-23       Impact factor: 3.252

4.  Responsiveness to nicotine of neurons of the caudal nucleus of the solitary tract correlates with the neuronal projection target.

Authors:  Lin Feng; Evgeny A Sametsky; Alexander G Gusev; Victor V Uteshev
Journal:  J Neurophysiol       Date:  2012-07-18       Impact factor: 2.714

5.  Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons.

Authors:  Timothy G J Allen; Fe C Abogadie; David A Brown
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

6.  Muscarinic stimulation of alpha1E Ca channels is selectively blocked by the effector antagonist function of RGS2 and phospholipase C-beta1.

Authors:  K Melliti; U Meza; B Adams
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.